This transaction
Acquisition of shares (making the company a subsidiary)The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.
AI consulting business and AI development support business
The impact of this transaction will be incorporated into the consolidated earnings forecast for the fiscal year ending December 2026 and is scheduled to be disclosed by the date of publication of the financial results summary for the second quarter of the fiscal year ending December 2026.
| Item | Details |
|---|---|
| Transaction name | Acquisition of shares (making the company a subsidiary) |
| Counterparty name | Matsumoto Yushin (松本 勇信) |
| Name of the Subject Company | 株式会社 EraX |
| Business Description of the Subject Company | AI consulting business and AI development support business |
| Location of the Subject Company | Minato-ku, Tokyo |
| Capital Stock of the Subject Company | ¥300 thousand |
| Date of Establishment of the Subject Company | 27 March 2024 |
| Net Sales of the Subject Company | ¥147,085,357 (March 2025 to February 2026; reference information) |
| Operating Profit of the Subject Company | ¥28,907,513 (March 2025 to February 2026; reference information) |
| Net Income of the Subject Company | ¥24,523,691 (March 2025 to February 2026; reference information) |
| Net Assets of the Subject Company | ¥24,987,292 (March 2025 to February 2026; reference information) |
| Acquisition price | ¥650 million |
| Expenses other than the acquisition price | Advisory fees and other costs (approximate amount): ¥35 million |
| Number of shares acquired | 10,000 shares (number of voting rights: 10,000) |
| Voting rights ownership percentage | Before 0% → after 100% |
| Impact on Business Performance | The impact of this transaction will be incorporated into the consolidated earnings forecast for the fiscal year ending December 2026 and is scheduled to be disclosed by the date of publication of the financial results summary for the second quarter of the fiscal year ending December 2026. |
| Date of board resolution | 25 May 2026 |
| Contract Date | 25 May 2026 |
| Execution Date / Effective Date | 23 June 2026 (予定) |
| Valuation methodology | DCF method (discounted cash flow method) |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To incorporate EraX's advanced AI technology and development capabilities and combine them with the Group's customer base, sales support expertise and human resources development functions, thereby promoting growth in AI-based services, strengthening the AI implementation support structure and expanding the AI talent development business.